Skip to main content
. Author manuscript; available in PMC: 2019 Dec 5.
Published in final edited form as: Sci Transl Med. 2018 Dec 5;10(470):eaau0965. doi: 10.1126/scitranslmed.aau0965

Fig. 4. Dynamic 11C-rifampin PET in a patient with TBM.

Fig. 4.

(A) Brain MRI fluid-attenuated inversion recovery (FLAIR) and post-gadolinium sequences. (B) Dynamic 11C-rifampin PET/CT fusion images and (C) TACs demonstrating 11C-rifampin exposures (Bq/ml) over 40 min in the plasma and brain (lesion and unaffected). (D) Mass spectrometry results for plasma rifampin and 25-desacetyl rifampin in this patient.